Nanomedicine in otorhinolaryngology future prospects;Nanomedizin in der HNO-Heilkunde ein Ausblick

Laryngo- Rhino- Otologie

Volumn 91, Issue 1, 2012, Pages 6-12

  Durr S ^a   Tietze, R ^a   Lyer, S ^a   Alexiou, C ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

drug delivery; magnetic drug targeting; nanomedicine; nanoparticles; otorhinolaryngology

Indexed keywords

ARTICLE; DATA BASE; DRUG DELIVERY SYSTEM; HEAD AND NECK SURGERY; MEDLINE; NANOMEDICINE; ONCOLOGY; OTORHINOLARYNGOLOGY; PRIORITY JOURNAL;

DRUG DELIVERY SYSTEMS; FORECASTING; GENE TRANSFER TECHNIQUES; NANOMEDICINE; NANOPARTICLES; OTOLARYNGOLOGY; OTORHINOLARYNGOLOGIC NEOPLASMS;

EID: 84855497580     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0031-1291339     Document Type: Article

References (69)

1. Feynman R P. Theres plenty of room at the bottom. 1959; http://www.zyvex.com/nanotech/feynman.html
2. Taniguchi N. On the basic concept of nanotechnology. In: Proc Intl Conf Prod Eng Part II. Tokyo Japan Society of Precision Engineering: 1974; 5 10
3. Krug H F, Wick P. Nanotoxikologie eine interdisziplinre Herausforderung. Angew Chem: 2011; 123 1294 1314
4. Philpott C M, Gane S, McKiernan D. Nanomedicine in otorhinolaryngology: what does the future hold? Eur Arch Otorhinolaryngol: 2011; 268 489 496
5. Bawa R, Bawa S R, Maebius S B, Flynn T, Wei C. Protecting new ideas and inventions in nanomedicine with patents. Nanomedicine: 2005; 1 150 158 (Pubitemid 43983075)
6. Wagner V, Wechsler D. Nanobiotechnologie II: Anwendungen in der Medizin und Pharmazie. Dsseldorf: VDI Technologiezentrum GmbH.: 2004
7. OECD/Allianz Group Small sizes that matter: Opportunities and Risks of Nanotechnologies: 2005
8. Praetorius M, Brunner C, Lehnert B, Klingmann C, Schmidt H, Staecker H, Schick B. Transsynaptic delivery of nanoparticles to the central auditory nervous system. Acta Otolaryngol: 2007; 127 486 490 (Pubitemid 46633777)
9. Thaler M, Roy S, Fornara A, Bitsche M, Qin J, Muhammed M, Salvenmoser W, Rieger G, Fischer A S, Glueckert R. Visualization and analysis of superparamagnetic iron oxide nanoparticles in the inner ear by light microscopy and energy filtered TEM. Nanomedicine: 2011; 7 360 369
10. Roy S, Johnston A H, Newman T A, Glueckert R, Dudas J, Bitsche M, Corbacella E, Rieger G, Martini A, Schrott-Fischer A. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: Potential tool for drug delivery. Int J Pharm: 2010; 390 214 224
11. Scheper V, Wolf M, Scholl M, Kadlecova Z, Perrier T, Klok H A, Saulnier P, Lenarz T, Stver T. Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine (Lond): 2009; 4 623 635
12. Chen G, Zhang X, Yang F, Mu L. Disposition of nanoparticle-based delivery system via inner ear administration. Curr Drug Metab: 2010; 11 886 897
13. Zhang W, Zhang Y, Lbler M, Schmitz K P, Ahmad A, Pyykk I, Zou J. Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells. Int J Nanomedicine: 2011; 6 535 546
14. Mondalek F G, Zhang Y Y, Kropp B, Kopke R D, Ge X, Jackson R L, Dormer K J. The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field. J Nanobiotechnology: 2006; 4 4
15. Shapiro B, Dormer K, Rutel I B. A Two-Magnet System to Push Therapeutic Nanoparticles. AIP Conf Proc: 2010; 1311 77 88
16. Zou J, Sood R, Ranjan S, Poe D, Ramadan U A, Kinnunen P K, Pyykk I. Manufacturing and in vivo inner ear visualization of MRI traceable liposome nanoparticles encapsulating gadolinium. J Nanobiotechnology: 2010; 8 32
17. Stver T, Lenarz T. Biomaterials in cochlear implants. Laryngo-Rhino-Otol: 2009; 88 S12 S31
18. Nair L S, Laurencin C T. Nanofibers and nanoparticles for orthopaedic surgery applications. J Bone Joint Surg Am: 2008; 90 128 131 (Pubitemid 351329131)
19. Dormer K, Seeney C, Lewelling K, Lian G, Gibson D, Johnson M. Epithelial internalization of superparamagnetic nanoparticles and response to external magnetic field. Biomaterials: 2005; 26 2061 2072
20. Kopke R D, Wassel R A, Mondalek F, Grady B, Chen K, Liu J, Gibson D, Dormer K J. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Audiol Neurootol: 2006; 11 123 133 (Pubitemid 43168184)
21. Srinivas A, Rao P J, Selvam G, Murthy P B, Reddy P N. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett: 2011; 205 105 115
22. Hackenberg S, Friehs G, Froelich K, Ginzkey C, Koehler C, Scherzed A, Burghartz M, Hagen R, Kleinsasser N. Intracellular distribution, geno- and cytotoxic effects of nanosized titanium dioxide particles in the anatase crystal phase on human nasal mucosa cells. Toxicol Lett: 2010; 195 9 14
23. Hackenberg S, Scherzed A, Technau A, Kessler M, Froelich K, Ginzkey C, Koehler C, Burghartz M, Hagen R, Kleinsasser N. Cytotoxic, genotoxic and pro-inflammatory effects of zinc oxide nanoparticles in human nasal mucosa cells in vitro. Toxicol In Vitro: 2011; 25 657 663
24. Bilberg K, Dving K B, Beedholm K, Baatrup E. Silver nanoparticles disrupt olfaction in Crucian carp (Carassius carassius) and Eurasian perch (Perca fluviatilis). Aquat Toxicol: 2011; 104 145 152
25. Griesenbach U, Geddes D M, Alton E W. Advances in cystic fibrosis gene therapy. Curr Opin Pulm Med: 2004; 10 542 546 (Pubitemid 39441451)
26. Lai S K, Suk J S, Pace A, Wang Y Y, Yang M, Mert O, Chen J, Kim J, Hanes J. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials: 2011; 32 6285 6290
27. Ellis-Behnke R G, Liang Y X, Tay D K, Kau P W, Schneider G E, Zhang S, Wu W, So K F. Nano hemostat solution: immediate hemostasis at the nanoscale. Nanomedicine: 2006; 2 115 207
28. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdrster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect: 2006; 114 1172 1178 (Pubitemid 44184673)
29. Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm: 2009; 379 146 157
30. Patel S, Chavhan S, Soni H, Babbar A K, Mathur R, Mishra A K, Sawant K. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. J Drug Target: 2011; 19 468 474
31. Kubek M J, Domb A J, Veronesi M C. Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles. Neurotherapeutics: 2009; 6 359 371
32. Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae. Clin Vaccine Immunol: 2011; 18 75 81
33. Miranda O R, Creran B, Rotello V M. Array-based sensing with nanoparticles: chemical noses for sensing biomolecules and cell surfaces. Curr Opin Chem Biol: 2010; 14 728 736
34. Allaker R P. The use of nanoparticles to control oral biofilm formation. J Dent Res: 2010; 89 1175 1186
35. McCarron P A, Donnelly R F, Canning P E, McGovern J G, Jones D S. Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis. Biomaterials: 2004; 25 2399 2407 (Pubitemid 38102393)
36. Goel H, Rai P, Rana V, Tiwary A K. Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul: 2008; 2 258 274
37. Venugopalan P, Sapre A, Venkatesan N, Vyas S P. Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization. Pharmazie: 2001; 56 217 219 (Pubitemid 32209946)
38. Kolachala V L, Henriquez O A, Shams S, Golub J S, Kim Y T, Laroui H, Torres-Gonzalez E, Brigham K L, Rojas M, Bellamkonda R V, Johns M M. Slow-release nanoparticle-encapsulated delivery system for laryngeal injection. Laryngoscope: 2010; 120 988 994
39. Xi J, Longest P W, Martonen T B. Effects of the laryngeal jet on nano- and microparticle transport and deposition in an approximate model of the upper tracheobronchial airways. J Appl Physiol: 2008; 104 1761 1777
40. Henning A, Schneider M, Nafee N, Muijs L, Rytting E, Wang X, Kissel T, Grafahrend D, Klee D, Lehr C M. Influence of particle size and material properties on mucociliary clearance from the airways. J Aerosol Med Pulm Drug Deliv: 2010; 23 233 241
41. Nauts H C, Fowler G A, Bogatko F H. A review of the influence of bacterial infection and of bacterial products (Coleys toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coleys mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med Scand: 1953; 276 1 103
42. Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia: 2010; 26 790 795
43. Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol: 2011; 103 317 324
44. Huilgol N G, Gupta S, Sridhar C R. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther: 2010; 6 492 496
45. Schmidtner J, Distel L V, Ott O J, Nkenke E, Sprung C N, Fietkau R, Lubgan D. Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes. Int J Hyperthermia: 2009; 25 347 354
46. Hainfeld J F, Dilmanian F A, Zhong Z, Slatkin D N, Kalef-Ezra J A, Smilowitz H M. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol: 2010; 55 3045 3059
47. Damascelli B, Patelli G, Tich V, Di Tolla G, Frigerio L F, Garbagnati F, Lanocita R, Marchian A, Spreafico C, Mattavelli F, Bruno A, Zunino F. Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx. J Vasc Interv Radiol: 2007; 18 1395 1403 (Pubitemid 47625995)
48. French J T, Goins B, Saenz M, Li S, Garcia-Rojas X, Phillips W T, Otto R A, Bao A. Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide. J Vasc Interv Radiol: 2010; 21 1271 1279
49. El-Sayed I H, Huang X, El-Sayed M A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett: 2006; 239 129 135 (Pubitemid 43946581)
50. Pankhurst Q A, Thanh NK T, Jones S K, Dobson J. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys: 2009; 42 224001 224016
51. Gao Y. Biofunctionalization of magnetic nanoparticles. In: Kumar C (Hrsg) Biofunctionalization of nanomaterials. Weinheim: Wiley-VCH: 2005; 72 98
52. Duerr S, Lyer S, Mann J, Janko C, Herrmann M, Tietze R, Schreiber E, Alexiou C. Real-Time Cell Analysis (RTCA) of human cancer cell lines after chemotherapy with functionalized magnetic nanoparticles. Anticancer Res: 2011; 31 1966 1967
53. Alexiou C, Jurgons R, Seliger C, Iro H. Medical applications of magnetic nanoparticles. J Nanosci Nanotechnol: 2006; 6 2762 2768 (Pubitemid 44579944)
54. Moskovitz B, Meyer G, Kravtzov A, Gross M, Kastin A, Biton K, Nativ O. Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients. Ann Oncol: 2005; 16 585 589 (Pubitemid 40613324)
55. Storm G, Belliot S O, Daemen T, Lasic D D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliver Rev: 1995; 17 31 48
56. Alexiou C, Tietze R, Schreiber E, Lyer S. Nanomedicine: Magnetic nanoparticles for drug delivery and hyperthermia new chances for cancer therapy. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2010; 53 839 845
57. Alexiou C, Diehl D, Henninger P, Iro H, Rockelein R, Schmidt W, Weber H. A high field gradient magnet for magnetic drug targeting. IEEE Trans Appl Supercond: 2006; 16 1527 1530 (Pubitemid 44150135)
58. Alexiou C, Jurgons R, Schmid R J, Bergemann C, Henke J, Erhardt W, Huenges E, Parak F. Magnetic drug targeting biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target: 2003; 11 139 149 (Pubitemid 37236327)
59. Tietze R, Rahn H, Lyer S, Schreiber E, Mann J, Odenbach S, Alexiou C. Visualization of superparamagnetic nanoparticles in vascular tissue using XCT and histology. Histochem Cell Biol: 2011; 135 153 158
60. Seliger C, Jurgons R, Wiekhorst F, Eberbeck D, Trahms L, Iro H, Alexiou C. In vitro investigation of the behaviour of magnetic particles by a circulating artery model. J Magn Magn Mater: 2007; 311 358 362 (Pubitemid 46401046)
61. Alexiou C, Jurgons R, Schmid R, Erhardt W, Parak F, Bergemann C, Iro H. Magnetic Drug Targeting a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies. HNO: 2005; 53 618 622 (Pubitemid 41151554)
62. Alexiou C, Arnold W, Hulin P, Klein R J, Renz H, Parak F G, Bergemann C, Lbbe A S. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J Magn Magn Mater: 2001; 225 187 193 (Pubitemid 32335295)
63. Rahn H, Gomez-Morilla I, Jurgons R, Alexiou Ch, Odenbach S. Microcomputed tomography analysis of ferrofluids used for cancer treatment. J Phys Condens Matter: 2008; 20 204152 204156
64. Alexiou C, Schmidt A, Klein R J, Hulin P, Bergemann C, Arnold W. Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magn Magn Mater: 2002; 252 363 366
65. Lyer S, Tietze R, Jurgons R, Struffert T, Engelhorn T, Schreiber E, Drfler A, Alexiou C. Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles a pilot study. Anticancer Res: 2010; 30 1553 1557
66. Alexiou C, Arnold W, Klein R J, Parak F G, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lbbe A S. Locoregional cancer treatment with magnetic drug targeting. Cancer Res: 2000; 60 6641 6648
67. WHO Cancer. Fact sheet N297, 2011. http://www.who.int/mediacentre/ factsheets/fs297/en/index.html
68. Unal B, Critchley J A, Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, 19812000: comparing contributions from primary prevention and secondary prevention. BMJ: 2005; 331 614
69. Harisinghani M G, Barentsz J, Hahn P F, Deserno W M, Tabatabaei S, van de Kaa C H, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med: 2003; 348 2491 2499 (Pubitemid 36706536)